ABK BioMedical Incorporated: federal grants and contributions: 6 agreements; $6.1M value; 2 departments; 4 programs.
Assay record ASY-CA-0QF9KX415X · Cite as: Assay Systems, “ABK BioMedical Incorporated: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/abk-biomedical-incorporated/
Design, develop and attain quality approval for manufacture of microspheres
Develop and commercialize next generation medical devices for interventional radiology
Development of technology to support the treatment of uterine fibroids
This project aims to develop resorbable hollow/porous/solid glass microspheres for precision transarterial embolization (TAE), with long-term variants as an additional option. Unlike permanent embolic agents, the resorbable radiopaque microspheres provide temporary occlusion, precise imaging, and safe, controlled degradation. Objectives include synthesizing tunable glass microsphere compositions, optimizing their structure for payload and delivery efficiencies, and confirming effectiveness in preclinical models. These versatile, biocompatible microspheres enhance TAE precision, minimize long-t
Hire a new CEO to advance the commercialization of the company's medical devices
Engage expertise to oversee the technical design and development of products
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.